Bank of New York Mellon Corp - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 46 filers reported holding ARATANA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$874,000
+45.9%
169,284
+1.7%
0.00%
Q1 2019$599,000
-40.5%
166,455
+1.4%
0.00%
Q4 2018$1,006,000
+16.4%
164,182
+11.0%
0.00%
Q3 2018$864,000
+36.7%
147,912
-0.5%
0.00%
Q2 2018$632,000
-1.4%
148,617
+2.2%
0.00%
Q1 2018$641,000
-15.7%
145,437
+0.6%
0.00%
Q4 2017$760,000
-10.9%
144,558
+4.0%
0.00%
Q3 2017$853,000
-14.0%
139,062
+1.4%
0.00%
Q2 2017$992,000
+48.7%
137,102
+8.9%
0.00%
Q1 2017$667,000
-28.4%
125,873
-2.9%
0.00%
Q4 2016$931,000
-27.5%
129,659
-5.6%
0.00%
Q3 2016$1,285,000
+48.4%
137,301
+0.3%
0.00%
Q2 2016$866,000
+33.8%
136,864
+16.7%
0.00%
Q1 2016$647,000
-10.9%
117,274
-9.9%
0.00%
Q4 2015$726,000
-44.5%
130,092
-15.9%
0.00%
Q3 2015$1,308,000
-47.4%
154,617
-6.1%
0.00%
-100.0%
Q2 2015$2,488,000
-21.7%
164,593
-17.1%
0.00%0.0%
Q1 2015$3,178,000
-9.0%
198,492
+1.3%
0.00%0.0%
Q4 2014$3,492,000
+162.4%
196,010
+47.8%
0.00%
Q3 2014$1,331,000
-68.5%
132,589
-51.0%
0.00%
-100.0%
Q2 2014$4,226,000
+178.2%
270,790
+230.9%
0.00%
Q1 2014$1,519,000
+157.9%
81,829
+165.4%
0.00%
Q4 2013$589,000
+31.5%
30,834
+12.8%
0.00%
Q3 2013$448,00027,3340.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,093,845$32,685,00011.00%
Broadfin Capital, LLC 1,634,870$25,520,0001.26%
MARXE AUSTIN W & GREENHOUSE DAVID M 600,000$9,366,0001.19%
Grandeur Peak Global Advisors, LLC 179,900$2,808,0000.60%
First Light Asset Management, LLC 52,234$815,0000.55%
Granite Point Capital Management, L.P. 50,000$781,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 788,904$12,315,0000.50%
ALYDAR PARTNERS LLC 180,000$2,810,0000.24%
CHARTWELL INVESTMENT PARTNERS, LLC 431,444$6,735,0000.14%
Nicholas Investment Partners, LP 141,127$2,203,0000.13%
View complete list of ARATANA THERAPEUTICS INC shareholders